$6.62
0.18[2.80%]
At close: Apr 26
$6.62
0[0.00%]
After Hours: 7:55PM EDT
ADMA Biologics
(NASDAQ:ADMA)Latest News for ADMA Biologics Stock (NASDAQ:ADMA)
ADMA Biologics Stock (NASDAQ: ADMA)
Categories: All
Thursday, April 25, 2024
Thursday, April 11, 2024
Tuesday, March 26, 2024
Monday, March 11, 2024
Friday, March 01, 2024
Thursday, February 29, 2024
- Cantor Fitzgerald Maintains Overweight on ADMA Biologics, Raises Price Target to $8Benzinga Newsdesk - Feb 29, 2024, 1:51PM
- Forecasting The Future: 4 Analyst Projections For ADMA BiologicsBenzinga Insights - Feb 29, 2024, 10:01AM
- HC Wainwright & Co. Reiterates Buy on ADMA Biologics, Maintains $6 Price TargetBenzinga Newsdesk - Feb 29, 2024, 9:05AM
Wednesday, February 28, 2024
- ADMA Biologics Sees FY24 And FY25 Total Revenue Above $330M And $380M, Respectively, Up From Prior Guidance Of $320M And $370M, RespectivelyBenzinga Newsdesk - Feb 28, 2024, 4:56PM
- Recap: ADMA Biologics Q4 EarningsBenzinga Insights - Feb 28, 2024, 4:30PM
- ADMA Biologics Q4 2023 Adj EPS $0.04 Beats $0.03 Estimate, Sales $73.90M Beat $72.15M EstimateBenzinga Newsdesk - Feb 28, 2024, 4:28PM
- ADMA Biologics Says Brian Lenz, Executive Vice President, CFO & General Manager, ADMA BioCenters Will Be Transitioning From These Positions To A Consulting Role, Effective April 1, 2024Benzinga Newsdesk - Feb 28, 2024, 4:27PM
- Earnings Scheduled For February 28, 2024Benzinga Insights - Feb 28, 2024, 6:24AM
Tuesday, February 27, 2024
Wednesday, February 21, 2024
Monday, January 22, 2024
Tuesday, January 09, 2024
Tuesday, December 19, 2023
Monday, December 18, 2023
Tuesday, December 12, 2023
Friday, November 17, 2023
Thursday, November 09, 2023
Wednesday, November 08, 2023
- ADMA Biologics Increases FY25 Revenue Exceeds $335MBenzinga Newsdesk - Nov 8, 2023, 5:35PM
- ADMA Biologics Increases FY24 Revenue Exceeds $290M Vs $278.4M Est.Benzinga Newsdesk - Nov 8, 2023, 5:34PM
- ADMA Biologics Increases FY23 Revenue Exceeds $250M Vs $243.06M Est.Benzinga Newsdesk - Nov 8, 2023, 5:33PM
- ADMA Biologics shares are trading higher after the company reported better-than-expected Q3 financial results.Benzinga Newsdesk - Nov 8, 2023, 4:42PM
- 12 Health Care Stocks Moving In Wednesday's After-Market SessionBenzinga Insights - Nov 8, 2023, 4:31PM
- ADMA Biologics Q3 EPS $0.01 Beats $(0.01) Estimate, Sales $67.28M Beat $62.12M EstimateBenzinga Newsdesk - Nov 8, 2023, 4:30PM
- Earnings Scheduled For November 8, 2023Benzinga Insights - Nov 8, 2023, 4:21AM
Tuesday, November 07, 2023
Thursday, August 31, 2023
Friday, August 18, 2023
Thursday, August 10, 2023
- Cantor Fitzgerald Maintains Overweight on ADMA Biologics, Raises Price Target to $6Benzinga Newsdesk - Aug 10, 2023, 12:58PM
- ADMA Biologics shares are trading higher after the company raised its FY23 revenue outlook.Benzinga Newsdesk - Aug 10, 2023, 12:54PM
- Raymond James Maintains Strong Buy on ADMA Biologics, Raises Price Target to $6Benzinga Newsdesk - Aug 10, 2023, 9:34AM
- HC Wainwright & Co. Maintains Buy on ADMA Biologics, Raises Price Target to $5Benzinga Newsdesk - Aug 10, 2023, 7:48AM
Wednesday, August 09, 2023
- ADMA Biologics Raises FY23 Revenue $240M Vs $226.03M EstBenzinga Newsdesk - Aug 9, 2023, 5:43PM
- ADMA Biologics Q2 EPS $(0.03) Misses $(0.02) Estimate, Sales $60.12M Beat $55.50M EstimateBenzinga Newsdesk - Aug 9, 2023, 4:24PM
- Earnings Scheduled For August 9, 2023Benzinga Insights - Aug 9, 2023, 4:54AM
Tuesday, August 08, 2023
Wednesday, July 19, 2023
- ADMA Biologics shares are trading higher after the company announced it received U.S. Food and Drug Administration approval for its ADMA BioCenters plasma collection facility.Benzinga Newsdesk - Jul 19, 2023, 11:15AM
- AT&T, Carvana, Northern Trust, And Other Big Stocks Moving Higher On WednesdayLisa Levin - Jul 19, 2023, 10:23AM
- The FDA Has Approved ADMA Biologics' Ninth ADMA Biocentres Plasma Collection Facility Located In Dallas, GA; The Plasma Collection Facility Commenced Operations And Initiated Source Plasma Collection In Q3 2022Benzinga Newsdesk - Jul 19, 2023, 7:05AM